Seizing Industry Momentum and Exploring Collaborative Future: Zhuhai Jinwan District Biopharma Investment Environment Promotion Event Successfully Held

On April 26, 2023, the Zhuhai Jinwan District Biopharmaceutical Investment Environment Promotion Conference, hosted by the People’s Government of Jinwan District (Development Zone), Zhuhai City, Guangdong Province, co-organized by Hengqin Financial Investment Group Co., Ltd., Zhuhai Jinhang Industrial Investment Group Co., Ltd., and Zhuhai Jinwan District Industrial Investment Promotion Co., Ltd., and undertaken by VCBeat, was successfully held in Shanghai.

Industry peers from the government, industrial, and investment sectors, along with representatives from over 40 enterprises in Jinwan District and various locations across Shanghai, convened at the event. Participants engaged in dynamic discussions on the development of Jinwan District’s biopharmaceutical industry, the latest industrial policies, insights from established companies, and investment opportunities. By exchanging ideas and best practices, they focused on industry hotspots and policy trends to explore new paradigms and pathways for the future growth of the biopharmaceutical sector.

As the largest, highest-output, and most maturely supported biopharmaceutical industry cluster in Zhuhai, Jinwan District has been continuously improving and optimizing its policy, funding, platform, and service frameworks. Its high-quality industrial ecosystem and service system have become the “gold-standard brand” of Jinwan District’s biopharmaceutical industry.

Feng Fengmei, Deputy District Mayor of Jinwan District in Zhuhai, provided a detailed introduction to the development of the biopharmaceutical industry in Jinwan District from three perspectives: transportation location, industrial status, and investment environment. Feng noted that Zhuhai, as one of China’s earliest established special economic zones, plays a pivotal role as a core city within the Guangdong-Hong Kong-Macao Greater Bay Area. As the “Golden Bay” at the heart of Zhuhai’s map and home to a national-level economic and technological development zone, Jinwan will continue to strengthen and expand its biopharmaceutical sector. It aims to reinforce Zhuhai’s leading role in the real economy, accelerate the construction of a “5+2+N” modern industrial system, and create an internationalized, law-based, and business-friendly environment. Leveraging its position as a core area of Zhuhai, Jinwan is poised to accommodate future industrial growth. The upcoming new round of biopharmaceutical policies in Jinwan District will provide coordinated support across the entire industry chain, accelerating the establishment of high-quality projects and enterprises in Jinwan.

In May last year, the JinQin Health Port project, jointly invested and constructed by Hengqin Financial Investment Group Co., Ltd. and Zhuhai Jinhang Industrial Investment Group Co., Ltd., broke ground. As a demonstration project for cooperation between municipal state-owned enterprises of Zhuhai City and district-level state-owned enterprises of Jinwan District, JinQin Health Port is positioned as a high-end, international comprehensive platform integrating industry, academia, research, sales, and services for biopharmaceuticals and high-end medical devices, aiming to establish a new highland for the pharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.

Zhang Weidong, Deputy General Manager of Zhuhai Jinqin Big Health Technology Co., Ltd., provided an in-depth analysis of how Hengqin JinTou empowers resident enterprises. He examined the current status and promising prospects of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area from the perspectives of financing, clinical resources, and industrial growth. Mr. Zhang also highlighted that since its establishment in 2014, Hengqin JinTou Group has consistently served strategic emerging industries over the past nine years. Looking ahead, the group aims to leverage a model combining industrial parks with financial service platforms, utilizing the amplifying effect of state-owned capital to attract more high-quality enterprises. By linking resources on both sides, they seek to continuously enrich Zhuhai’s biopharmaceutical industry cluster and achieve mutual benefits.

Pei Xinxin, Head of Biopharmaceutical Investment Promotion at Zhuhai Jinhang Group, addressed two fundamental questions: “Why choose Zhuhai International Health Port?” and “What tangible benefits can tenants expect?” He introduced Zhuhai International Health Port as a specialized, high-end, and international biopharmaceutical industrial park in the Guangdong-Hong Kong-Macao Greater Bay Area, integrating industry, academia, research, sales, and services. Its high-quality supporting facilities, “5+2” service platform, and industry-research collaboration models have attracted a series of pharmaceutical companies. After settling in, enterprises will receive substantial support for their development through various measures, including a series of preferential policies, the “Jinying Plan,” and access to market resources, thereby fostering a more robust ecosystem for industrial innovation.

As the biopharmaceutical industry continues to flourish, enterprises must target future industry frontiers, identify synergies for industrial innovation, and strengthen investment momentum and strategic development layouts to truly achieve win-win collaboration and usher in a surge of industry growth. At the conference, representatives from Zhuhai Dipu Medical Technology Co., Ltd. and By-Health Co., Ltd. jointly explored investment opportunities in the era of life and holistic health from the perspectives of biopharmaceuticals and medical devices, respectively.

Mr. Cai Jinchun, General Manager of Zhuhai Dipu Medical Technology Co., Ltd., presented Dipu Medical’s development agenda and its partnership opportunities with Jinwan District and Zhuhai Health Port from the perspective of biomedicine, under the theme “Acting in Accordance with the Times, Seizing Opportunities, and Co-creating the Future.” He also explored in depth how enterprises should “respond to the times” to align with the trend of integrating government, enterprise, and investment sectors. Mr. Cai emphasized that companies must first clearly define their development positioning and dimensions, noting that independent innovation is particularly crucial given the current momentum in China’s domestic medical device industry. He further pointed out that the growth of a high-quality enterprise relies on resource allocation, policy support, and investment. As enterprises thrive in a dynamic environment, they will, in turn, contribute to the continuous improvement and optimization of that environment, ultimately achieving the goal of coordinated development.

Jiang Gang, Deputy General Manager of By-Health Co., Ltd., provided a detailed overview of the company’s development in Jinwan District, Zhuhai, over the past 15 years, as well as its future plans. Jiang noted that By-Health has consistently prioritized original research and development to build differentiated competitiveness, develop products with novel functionalities, and continuously refine innovative technologies. The company aims to transform into a technology-driven enterprise in the future. As a beneficiary of local policies, By-Health has received various incentives since establishing its presence in Jinwan, including rewards for headquarters economy contributions, investment attraction, technological innovation, and talent acquisition. Jiang expressed firm confidence that both Jinwan District, Zhuhai, and By-Health will continue to thrive, advancing toward the goal of creating a global “United Nations” of nutritional supplements.

“Shanghai and Zhuhai Join Hands for a Win-Win Future!” We believe that the successful holding of this conference will further boost the development of Zhuhai’s biopharmaceutical industry ecosystem, contributing to the establishment of a world-class biopharmaceutical industry cluster. We also look forward to Shanghai and Zhuhai generating more waves of collaborative development, extending bridges for exchange and interaction, pooling development strengths, and achieving win-win cooperation!